다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

MYGN

Myriad Genetics (MYGN)

Myriad Genetics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:MYGN

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/24	07:00	GlobeNewswire Inc.	Myriad Genetics Showcases New Research and Product Innovations Advancing Cancer Care at 2024 ASCO® Annual Meeting	NASDAQ:MYGN	Myriad Genetics Inc
2024/05/17	05:05	GlobeNewswire Inc.	New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate Cancer	NASDAQ:MYGN	Myriad Genetics Inc
2024/05/16	06:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MYGN	Myriad Genetics Inc
2024/05/16	06:48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MYGN	Myriad Genetics Inc
2024/05/16	05:24	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MYGN	Myriad Genetics Inc
2024/05/15	05:26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MYGN	Myriad Genetics Inc
2024/05/14	05:24	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MYGN	Myriad Genetics Inc
2024/05/14	01:14	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MYGN	Myriad Genetics Inc
2024/05/08	21:23	IH Market News	Reddit Rises 15% After First Quarterly Report, Upstart and Twilio Plunge Due to Weak Q2 Forecast, and More in Earnings	NASDAQ:MYGN	Myriad Genetics Inc
2024/05/08	21:14	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MYGN	Myriad Genetics Inc
2024/05/08	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MYGN	Myriad Genetics Inc
2024/05/08	05:05	GlobeNewswire Inc.	Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDA	NASDAQ:MYGN	Myriad Genetics Inc
2024/05/07	22:00	GlobeNewswire Inc.	Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict Business	NASDAQ:MYGN	Myriad Genetics Inc
2024/05/01	05:05	GlobeNewswire Inc.	Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024	NASDAQ:MYGN	Myriad Genetics Inc
2024/04/17	21:00	GlobeNewswire Inc.	Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health Monitor	NASDAQ:MYGN	Myriad Genetics Inc
2024/04/16	22:15	GlobeNewswire Inc.	New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen	NASDAQ:MYGN	Myriad Genetics Inc
2024/04/09	21:00	GlobeNewswire Inc.	Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing	NASDAQ:MYGN	Myriad Genetics Inc
2024/03/22	10:40	GlobeNewswire Inc.	Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date	NASDAQ:MYGN	Myriad Genetics Inc
2024/03/21	05:05	GlobeNewswire Inc.	Myriad Genetics Announces Patent Granted for SneakPeek® Snap Device	NASDAQ:MYGN	Myriad Genetics Inc
2024/03/05	06:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MYGN	Myriad Genetics Inc
2024/02/28	22:31	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:MYGN	Myriad Genetics Inc
2024/02/28	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MYGN	Myriad Genetics Inc
2024/02/28	06:05	GlobeNewswire Inc.	Myriad Genetics Reports Strong Fourth Quarter and Full-Year 2023 Financial Results; Fourth Quarter Revenue of $197 Million and Full-Year Revenue of $753 Million Each Grew 11% Year-Over-Year; Delivered GAAP EPS of $(0.36) and Adjusted EPS of $0.04 in the Fo	NASDAQ:MYGN	Myriad Genetics Inc
2024/02/27	23:15	GlobeNewswire Inc.	Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Monitoring Clinical Trial, SCRUM-MONSTAR-SCREEN-3	NASDAQ:MYGN	Myriad Genetics Inc
2024/02/27	06:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MYGN	Myriad Genetics Inc
2024/02/27	06:09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MYGN	Myriad Genetics Inc
2024/02/22	06:05	GlobeNewswire Inc.	Myriad Genetics to Release Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024	NASDAQ:MYGN	Myriad Genetics Inc
2024/02/16	06:05	GlobeNewswire Inc.	Myriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor of Women’s Health	NASDAQ:MYGN	Myriad Genetics Inc
2024/02/15	06:47	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:MYGN	Myriad Genetics Inc
2024/02/14	22:24	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:MYGN	Myriad Genetics Inc

검색 관련기사 보기:NASDAQ:MYGN

1 2 3 4 5 6 7 8 9 10 다음 >>

HighYield Income ClosedE...

T Rex 2X Long NVIDIA Dai...

ELETT400 Ex:39,6

Silver Bull Res

B&S Banksysteme Aktienges

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관